View in EDS

Saruparib in combination with androgen receptor pathway inhibitors in metastatic hormone-sensitive prostate cancer: EvoPAR-Prostate01.

Saved in:
Bibliographic Details
Title: Saruparib in combination with androgen receptor pathway inhibitors in metastatic hormone-sensitive prostate cancer: EvoPAR-Prostate01.
Authors: Azad AA; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Agarwal N; Division of Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Armstrong AJ; Department of Medicine, Duke Cancer Institute Center for Prostate and Urologic Cancer, Duke University Medical Center, Durham, NC, USA., Hellmis E; Urologicum Duisburg, Center for Urology and Urologic Cancer, Duisburg, Germany., Sugimoto M; Department of Urology, Kagawa University, Kagawa, Japan., Ürün Y; Department of Medical Oncology, Ankara University School of Medicine, Ankara, Turkey., Xing N; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Aregay M; Global Medicines Development, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA., Lima J; Global Medicines Development, Oncology R&D, AstraZeneca, Cambridge, UK., Meulendijks D; Global Medicines Development, Oncology R&D, AstraZeneca, Barcelona, Spain., Chi KN; Department of Medical Oncology, University of British Columbia, Vancouver, BC, Canada.
Source: Future oncology (London, England) [Future Oncol] 2026 Apr; Vol. 22 (10), pp. 1153-1163. Date of Electronic Publication: 2026 Apr 14.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41979035
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Saruparib in combination with androgen receptor pathway inhibitors in metastatic hormone-sensitive prostate cancer: EvoPAR-Prostate01.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Azad+AA%22">Azad AA</searchLink>; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Agarwal+N%22">Agarwal N</searchLink>; Division of Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Armstrong+AJ%22">Armstrong AJ</searchLink>; Department of Medicine, Duke Cancer Institute Center for Prostate and Urologic Cancer, Duke University Medical Center, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Hellmis+E%22">Hellmis E</searchLink>; Urologicum Duisburg, Center for Urology and Urologic Cancer, Duisburg, Germany.<br /><searchLink fieldCode="AU" term="%22Sugimoto+M%22">Sugimoto M</searchLink>; Department of Urology, Kagawa University, Kagawa, Japan.<br /><searchLink fieldCode="AU" term="%22Ürün+Y%22">Ürün Y</searchLink>; Department of Medical Oncology, Ankara University School of Medicine, Ankara, Turkey.<br /><searchLink fieldCode="AU" term="%22Xing+N%22">Xing N</searchLink>; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Aregay+M%22">Aregay M</searchLink>; Global Medicines Development, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Lima+J%22">Lima J</searchLink>; Global Medicines Development, Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Meulendijks+D%22">Meulendijks D</searchLink>; Global Medicines Development, Oncology R&D, AstraZeneca, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Chi+KN%22">Chi KN</searchLink>; Department of Medical Oncology, University of British Columbia, Vancouver, BC, Canada.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101256629%22">Future oncology (London, England)</searchLink> [Future Oncol] 2026 Apr; Vol. 22 (10), pp. 1153-1163. <i>Date of Electronic Publication: </i>2026 Apr 14.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101256629 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-8301 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214796694%22">14796694 </searchLink><i>NLM ISO Abbreviation: </i>Future Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41979035
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/14796694.2026.2655433
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1153
    Titles:
      – TitleFull: Saruparib in combination with androgen receptor pathway inhibitors in metastatic hormone-sensitive prostate cancer: EvoPAR-Prostate01.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Azad AA
      – PersonEntity:
          Name:
            NameFull: Agarwal N
      – PersonEntity:
          Name:
            NameFull: Armstrong AJ
      – PersonEntity:
          Name:
            NameFull: Hellmis E
      – PersonEntity:
          Name:
            NameFull: Sugimoto M
      – PersonEntity:
          Name:
            NameFull: Ürün Y
      – PersonEntity:
          Name:
            NameFull: Xing N
      – PersonEntity:
          Name:
            NameFull: Aregay M
      – PersonEntity:
          Name:
            NameFull: Lima J
      – PersonEntity:
          Name:
            NameFull: Meulendijks D
      – PersonEntity:
          Name:
            NameFull: Chi KN
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2026 Apr
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1744-8301
          Numbering:
            – Type: volume
              Value: 22
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Future oncology (London, England)
              Type: main
ResultId 1